Dynasty Wealth Management
VRTX icon

Dynasty Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Dynasty Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$440K Buy
842
+9
+1% +$4.61K ﹤0.01% 251
2026
Q2 		$414K Sell
833
-216
-21% -$95.7K ﹤0.01% 282
2026
Q1 		$468K Buy
1,049
+36
+4% +$16.8K ﹤0.01% 242
2025
Q4 		$459K Buy
+1,013
New +$437K ﹤0.01% 245

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Dynasty Wealth Management's VRTX Position: Q3 2026 in Review

Dynasty Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q3 2026, buying an estimated $4.61K and bringing the position to 842 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #251.

Dynasty Wealth Management first reported a position in VRTX in Q4 2025 and has held it in 4 quarters since. The position peaked at $468K in Q1 2026. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Dynasty Wealth Management held 842 shares of Vertex Pharmaceuticals worth $440K as of Q3 2026.
  • Dynasty Wealth Management bought 9 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.61K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q3 2026, its #251 holding.
  • Dynasty Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Dynasty Wealth Management's Vertex Pharmaceuticals position peaked at $468K in Q1 2026.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Dynasty Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.